|
Notice:
|
|
Suspension of shipments during Golden Week Holidays: From 30 April to 14 May, deadline 17 April.
|
|
| NIG-RNAi Strains Detail |
| Request : Click the "Order" button to request for this stock |
discarded
|
| Stock Detail (Last Update: November 2007_FlyBase version FB2007_11) |
| Stock ID |
31968R-2 |
| Symbol |
dp |
Full Name |
dumpy |
| CG No |
CG33196 |
Old CG No |
CG31968 |
| Synonyms |
Dp, CT35799, CG15637, SP460, DP, olv[D], l(2)24Fd, CR33195, CG31966, CG31968, CG31967, CG33000, CG31725, CG31727, CG33086, CG31965, CG31964, CG31726, CG31724, CG33196, BcDNA:SD02173, dp |
| Accession No (Link to NCBI) |
NM_175960.3 |
| Inserted Chr. |
lll |
| Insertional Mutation |
lethal |
| Phenotype induced by Act5C-GAL4 at 28 degrees |
viable |
| Map Viewer |
|
Reference
[Please submit your publication]
|
Tiwari P, Kumar A, Das RN, Malhotra V, VijayRaghavan K.
A Tendon Cell Specific RNAi Screen Reveals Novel Candidates Essential for Muscle Tendon Interaction.
PLoS One (2015) 10(10) e0140976
[
PubMed ID = 26488612
]
[
RRC reference
]
|
| Comment |
|
| Sequence (Last Update: July 10, 2007_NCBI RefSeq Release 24) |
| Primer Seq. 5' |
aaggcctacatggccggaccgAACCACTGTCGCATCAATCAC |
| Primer Seq. 3' |
aatctagaggtaccCGCTCGGAGAAGATGTAGTTT |
| Predicted Fragment Size |
500 |
| IR fragment full Seq |
0001 AACCACTGTC GCATCAATCA CCTCAGAATC CACTACCAGA GAAGTATATA CCATCAAGCC
0061 CTTCGATAGA TCTACTCCCA CTCCAGTATC GCCGGACACT ACTGTTCCAT CAATCACTTT
0121 TGAAACCACC ACAAATATTC CGATTGGAAC AACACGAGGG CAAGTGACAG AACCAGACTA
0181 CATCTTCTCC CAGCGAAAAG AGAACTACAA TACGTGTTGA AGAATCTACA CTTCCTTCTA
0241 GGTCAACGGA TAGAACCACT CCATCCGAAA GTCCTGAGAC ACCCACAATA TTACCTTCAG
0301 ACTCCACTAC TCGAACTTAC TCAGATCAAA CGACTGAATC TACTAGAGAC GTTCCAACCA
0361 CCCGGCCATT TGAGGCATCT ACTCCCAGBC CAGCATCTCT GGAAACAACT GTTCCATCAG
0421 TTACTTTAGA AACCACTACA AATGATCCAA TCGGTTCAAC AGGTGGGCAA GTGACAGAAC
0481 AAACTACATC TTCTCCGAGC G |
| in silico PCR Fragment |
0001 AACCACTGTC GCATCAATCA CCTCAGAATC CACTACCAGA GAAGTATATA CCATCAAGCC
0061 CTTCGATAGA TCTACTCCCA CTCCAGTATC GCCGGACACT ACTGTTCCAT CAATCACTTT
0121 TGAAACCACC ACAAATATTC CGATTGGAAC AACACGAGGG CAAGTGACAG AA-CAGACTA
0181 CATCTTCTCC CAGCGAAAAG AGAACTACAA TACGTGTTGA AGAATCTACA CTTCCTTCTA
0241 GGTCAACGGA TAGAACCACT CCATCCGAAA GTCCTGAGAC ACCCACAATA TTACCTTCAG
0301 ACTCCACTAC TCGAACTTAC TCAGATCAAA CGACTGAATC TACTAGAGAC GTTCCAACCA
0361 CCCGGCCATT TGAGGCATCT ACTCCCAGTC CAGCATCTCT GGAAACAACT GTTCCATCAG
0421 TTACTTTAGA AACCACTACA AATGATCCAA TCGGTTCAAC AGGTGGGCAA GTGACAGAAC
0481 AAACTACATC TTCTCCGAGC G |
| Assemble Data |
31968R-2.IR_full 1 AACCACTGTCGCATCAATCACCTCAGAATCCACTACCAGAGAAGTATATACCATCAAGCC 60
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 1 AACCACTGTCGCATCAATCACCTCAGAATCCACTACCAGAGAAGTATATACCATCAAGCC 60
31968R-2.IR_full 61 CTTCGATAGATCTACTCCCACTCCAGTATCGCCGGACACTACTGTTCCATCAATCACTTT 120
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 61 CTTCGATAGATCTACTCCCACTCCAGTATCGCCGGACACTACTGTTCCATCAATCACTTT 120
31968R-2.IR_full 121 TGAAACCACCACAAATATTCCGATTGGAACAACACGAGGGCAAGTGACAGAACCAGACTA 180
|||||||||||||||||||||||||||||||||||||||||||||||||||| |||||||
31968R-2.in silico 121 TGAAACCACCACAAATATTCCGATTGGAACAACACGAGGGCAAGTGACAGAA-CAGACTA 180
31968R-2.IR_full 181 CATCTTCTCCCAGCGAAAAGAGAACTACAATACGTGTTGAAGAATCTACACTTCCTTCTA 240
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 181 CATCTTCTCCCAGCGAAAAGAGAACTACAATACGTGTTGAAGAATCTACACTTCCTTCTA 240
31968R-2.IR_full 241 GGTCAACGGATAGAACCACTCCATCCGAAAGTCCTGAGACACCCACAATATTACCTTCAG 300
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 241 GGTCAACGGATAGAACCACTCCATCCGAAAGTCCTGAGACACCCACAATATTACCTTCAG 300
31968R-2.IR_full 301 ACTCCACTACTCGAACTTACTCAGATCAAACGACTGAATCTACTAGAGACGTTCCAACCA 360
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 301 ACTCCACTACTCGAACTTACTCAGATCAAACGACTGAATCTACTAGAGACGTTCCAACCA 360
31968R-2.IR_full 361 CCCGGCCATTTGAGGCATCTACTCCCAGBCCAGCATCTCTGGAAACAACTGTTCCATCAG 420
|||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||
31968R-2.in silico 361 CCCGGCCATTTGAGGCATCTACTCCCAGTCCAGCATCTCTGGAAACAACTGTTCCATCAG 420
31968R-2.IR_full 421 TTACTTTAGAAACCACTACAAATGATCCAATCGGTTCAACAGGTGGGCAAGTGACAGAAC 480
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31968R-2.in silico 421 TTACTTTAGAAACCACTACAAATGATCCAATCGGTTCAACAGGTGGGCAAGTGACAGAAC 480
31968R-2.IR_full 481 AAACTACATCTTCTCCGAGCG 501
|||||||||||||||||||||
31968R-2.in silico 481 AAACTACATCTTCTCCGAGCG 501
|
| Off-target information (Last Update: November 4, 2007_NCBI RefSeq Release 26) |
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
| cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
| 880.49 |
4244 |
3874 |
2502 |
2143 |
NM_175960.3 |
CG33196-RB (dp), mRNA |
| 0 |
0 |
2 |
7 |
2 |
NM_140577.1 |
CG5284-RB, transcript variant B (CG5284), mRNA |
| 0 |
0 |
2 |
7 |
2 |
NM_168650.1 |
CG5284-RA, transcript variant A (CG5284), mRNA |
| 0 |
0 |
1 |
4 |
3 |
NM_080004.2 |
CG5284-RA, transcript variant A (CG5284), mRNA, ankyrin repeat, tyrosine kinase CG18247-RA (shark), mRNA |
| 0 |
0 |
0 |
6 |
4 |
NM_142297.2 |
CG14900-RA (Cad89D), mRNA |
| 0 |
0 |
0 |
5 |
8 |
NM_079990.2 |
CG15667-RA, transcript variant A (Sara), mRNA |
| 0 |
0 |
0 |
5 |
8 |
NM_166451.1 |
CG15667-RB, transcript variant B (Sara), mRNA |
| 0 |
0 |
0 |
5 |
7 |
NM_140431.2 |
CG6451-RA (blue), mRNA |
| 0 |
0 |
0 |
4 |
6 |
NM_165089.2 |
CG3479-RA, transcript variant A (osp), mRNA |
| 0 |
0 |
0 |
4 |
5 |
NM_078843.4 |
CG3479-RB, transcript variant B (osp), mRNA |
| 0 |
0 |
0 |
4 |
3 |
NM_079432.2 |
CG9750-RA (rept), mRNA |
| 0 |
0 |
0 |
3 |
8 |
NM_057832.3 |
CG5393-RA, transcript variant A (apt), mRNA |
| 0 |
0 |
0 |
3 |
5 |
NM_078724.4 |
CG13948-RA (Gr21a), mRNA |
| 0 |
0 |
0 |
3 |
5 |
NM_169676.1 |
CG31150-RA (CG31150), mRNA |
| 0 |
0 |
0 |
3 |
4 |
NM_135518.1 |
CG5676-RA (CG5676), mRNA |
| 0 |
0 |
0 |
3 |
4 |
NM_134841.1 |
CG15393-RA (CG15393), mRNA |
| 0 |
0 |
0 |
3 |
2 |
NM_135636.1 |
CG14913-RA (CG14913), mRNA |
| 0 |
0 |
0 |
3 |
2 |
NM_166663.1 |
CG13569-RB, transcript variant B (CG13569), mRNA |
| 0 |
0 |
0 |
3 |
2 |
NM_138044.2 |
CG13569-RA, transcript variant A (CG13569), mRNA |
| 0 |
0 |
0 |
2 |
9 |
NM_142354.1 |
CG4090-RA (CG4090), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_134786.4 |
CG7337-RA, transcript variant A (CG7337), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_206287.1 |
CG8571-RB, transcript variant B (smid), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_001042862.1 |
CG7337-RC, transcript variant C (CG7337), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_079235.2 |
CG8571-RA, transcript variant A (smid), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_135492.3 |
CG4747-RA (CG4747), mRNA |
| 0 |
0 |
0 |
2 |
6 |
NM_001042863.1 |
CG7337-RB, transcript variant B (CG7337), mRNA |
| 0 |
0 |
0 |
2 |
5 |
NM_132298.3 |
CG7039-RA (CG7039), mRNA |
| 0 |
0 |
0 |
2 |
4 |
NM_136715.2 |
CG18011-RA (CG18011), mRNA |
| 0 |
0 |
0 |
2 |
4 |
NM_168129.1 |
CG5486-RA, transcript variant A (Ubp64E), mRNA |
| 0 |
0 |
0 |
2 |
4 |
NM_136712.2 |
CG30011-RC, transcript variant C (gem), mRNA |
|
|
|
